Physician profile
Sandy Kuo
NPI 1023438785
$11,187.95
in general payments reported to CMS, 2019-2025
41 companies · $2,228 in 2025
The $2,228 reported for 2025 was more than what 78% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,395 · 2020: $213 · 2021: $437 · 2022: $1,299 · 2023: $3,095 · 2024: $2,520 · 2025: $2,228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,728 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,728.11 |
| Education | $115.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,771.63 | 2019-2025 | |
| Genzyme Corporation | $1,318.76 | 2019-2025 | |
| Janssen Biotech, INC. | $861.18 | 2021-2025 | Tremfya, Simponi Aria, Stelara |
| Novartis Pharmaceuticals Corporation | $790.23 | 2019-2025 | |
| Leo Pharma INC. | $703.88 | 2019-2025 | Adbry, Anzupgo |
| Ucb, INC. | $564.78 | 2019-2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $515.98 | 2021-2025 | Dupixent, Libtayo |
| Pfizer INC. | $500.99 | 2019-2025 | |
| Lilly USA, LLC | $448.28 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Amgen INC. | $333.22 | 2022-2025 | Otezla, Otezla |
| Merz North America, INC. | $313.78 | 2020-2025 | |
| Incyte Corporation | $303.16 | 2022-2025 | Opzelura |
| Almirall LLC | $295.47 | 2022-2025 | Seysara, Klisyri |
| Allergan, INC. | $268.61 | 2019-2022 | |
| Galderma Laboratories, L.P. | $242.62 | 2019-2025 | Nemluvio, Aklief |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandy Kuo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.